Bourrier, C.; Pierga, J.-Y.; Xuereb, L.; Salaun, H.; Proudhon, C.; Speicher, M.R.; Belic, J.; Heitzer, E.; Lockhart, B.P.; Guigal-Stephan, N.
Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival. Cancers 2020, 12, 1481.
https://doi.org/10.3390/cancers12061481
AMA Style
Bourrier C, Pierga J-Y, Xuereb L, Salaun H, Proudhon C, Speicher MR, Belic J, Heitzer E, Lockhart BP, Guigal-Stephan N.
Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival. Cancers. 2020; 12(6):1481.
https://doi.org/10.3390/cancers12061481
Chicago/Turabian Style
Bourrier, Chantal, Jean-Yves Pierga, Laura Xuereb, Hélène Salaun, Charlotte Proudhon, Michael R. Speicher, Jelena Belic, Ellen Heitzer, Brian Paul Lockhart, and Nolwen Guigal-Stephan.
2020. "Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival" Cancers 12, no. 6: 1481.
https://doi.org/10.3390/cancers12061481
APA Style
Bourrier, C., Pierga, J. -Y., Xuereb, L., Salaun, H., Proudhon, C., Speicher, M. R., Belic, J., Heitzer, E., Lockhart, B. P., & Guigal-Stephan, N.
(2020). Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival. Cancers, 12(6), 1481.
https://doi.org/10.3390/cancers12061481